AVORO CAPITAL ADVISORS LLC 13D and 13G filings for Madrigal Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 09:21 am Purchase |
2023-12-31 | 13G | Madrigal Pharmaceuticals, Inc. MDGL |
AVORO CAPITAL ADVISORS LLC | 2,288,888 9.900% |
628,888 (+37.88%) |
Filing |
| 2023-02-14 09:37 am Purchase |
2022-12-31 | 13G | Madrigal Pharmaceuticals, Inc. MDGL |
AVORO CAPITAL ADVISORS LLC | 1,660,000 9.700% |
235,000 (+16.49%) |
Filing |
| 2022-02-11 10:03 am Purchase |
2021-12-31 | 13G | Madrigal Pharmaceuticals, Inc. MDGL |
AVORO CAPITAL ADVISORS LLC | 1,425,000 8.300% |
200,000 (+16.33%) |
Filing |
| 2021-02-12 08:06 am Purchase |
2020-12-31 | 13G | Madrigal Pharmaceuticals, Inc. MDGL |
AVORO CAPITAL ADVISORS LLC | 1,225,000 7.900% |
1,225,000 (New Position) |
Filing |